Evidence map›Paper›PMID 29098331›Full record

ReviewThe Journal of membrane biology2018

Essential Two-Component Systems Regulating Cell Envelope Functions: Opportunities for Novel Antibiotic Therapies.

Silvia T Cardona, Matthew Choy, Andrew M Hogan

Abstract readReview
PubMed Publisher
In one paragraph

Review in The Journal of membrane biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 40 citations in OpenAlex.

  1. Specificities of chemosensory receptors in the human gut microbiota.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Article
  3. Microbiology spectrum · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Methodological tools to study species of the genus Burkholderia.Applied microbiology and biotechnology · 2021
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Signal Transduction Proteins inFrontiers in microbiology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Silvia T CardonaDepartment of Microbiology, University of Manitoba, Buller Building, Room 213, Winnipeg, MB, R3T 2N2, Canada. Silvia.Cardona@umanitoba.ca.ORCID 0000-0002-0629-8886
Matthew ChoyDepartment of Medical Microbiology & Infectious Disease, University of Manitoba, Winnipeg, MB, Canada.
Andrew M HoganDepartment of Microbiology, University of Manitoba, Buller Building, Room 213, Winnipeg, MB, R3T 2N2, Canada.
University of Manitoba · CA

Funding

Cystic Fibrosis Canada 2600Natural Sciences and Engineering Research Council of Canada (CA) 615992
6 · The paper itself

Abstract

Novel therapies are urgently needed to alleviate the current crisis of multiple drug-resistant infections. The bacterial signal transduction mechanisms, known as two-component systems (TCSs), are ideal targets of novel inhibitory molecules. Highly restricted to the bacterial world, TCSs control a diverse set of cellular functions, namely virulence, response to cell envelope stress, and drug efflux. Impaired regulation of any of these aspects could affect the susceptibility of bacterial pathogens to antibiotics, which highlights the potential of TCS as targets of antibiotic adjuvant therapies. Moreover, new high-density transposon mutagenesis methods have revealed the existence of TCSs required for growth and viability. Experimental validation of gene essentiality and phenotypic characterization of knockdown mutants indicate that essential TCSs regulate aspects of the cell envelope homeostasis in coordination with cell division. In this review, we describe essential TCSs, and their potentials as targets for antibacterial molecules. We also discuss methods for the identification of small molecules that inhibit TCSs and possible reasons why antibacterial molecules targeting essential TCSs have not yet reached clinical trials.

Indexed as

Anti-Bacterial AgentsBacteriaBacterial ProteinsDNA Transposable ElementsGene Expression Regulation, BacterialSignal TransductionVirulenceAnti-Bacterial AgentsBacterial ProteinsDNA Transposable ElementsAntibiotic targetEssential genesTwo-component system

Identifiers

PMID29098331
OpenAlexW2765915958

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.